Related Experiment Video
Updated: Aug 16, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
Teaching cancer cells to die
1Novartis Institute for Biomedical Research, Oncology Biology, East Hanover, New Jersey 07936, USA. leigh.zawel@pharma.novartis.com
Abstract:
Tumor cells have evolved numerous mechanisms to thwart apoptosis. As our understanding of the machinery which regulates cell-death evolves, these apoptotic defects have fallen into the crosshairs of cancer drug developers. The issues raised in exploiting these alterations for therapeutic benefit are discussed.
Insights
Cancer cells resist cell death through various mechanisms. This review discusses how targeting these apoptotic defects presents therapeutic opportunities for cancer drug development.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Tumor cells possess multiple strategies to evade programmed cell death (apoptosis).
- Understanding the molecular regulation of apoptosis is crucial for cancer therapy.
- Defects in apoptosis pathways are a hallmark of cancer.
Purpose of the Study:
- To review the mechanisms by which tumor cells evade apoptosis.
- To discuss the therapeutic potential of targeting apoptotic defects in cancer.
- To highlight the challenges and opportunities in developing drugs that exploit these alterations.
Main Methods:
- Literature review of cancer cell apoptosis evasion.
- Analysis of molecular pathways regulating programmed cell death.
- Discussion of drug development strategies targeting apoptosis.
Main Results:
- Tumor cells utilize diverse mechanisms to inhibit apoptosis.
- Targeting these apoptotic defects is a promising area for cancer drug discovery.
- Exploiting these vulnerabilities requires overcoming specific biological hurdles.
Conclusions:
- Apoptotic defects in cancer cells offer viable targets for novel therapeutics.
- Further research into apoptosis regulation can yield new anti-cancer strategies.
- Developing effective drugs requires a deep understanding of cancer's evasion tactics.
Related Concept Videos
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

